Intrauterine Devices Market by Product Type (Hormonal IUDs, Non-Hormonal (Copper) IUDs), by Age Group (20 to 24 Years, 25 to 34 Years, 35 to 44 Years, Above 44 Years), by End Use (Hospitals, Gynecology Clinics, Community Healthcare Centers), and by Region; Global Insights & Forecast (2024 - 2030)

As per Intent Market Research, the Intrauterine Devices Market was valued at USD 3.9 billion in 2023 and will surpass USD 7.1 billion by 2030; growing at a CAGR of 9.0% during 2024 - 2030.

The intrauterine devices (IUDs) market is a pivotal sector within the reproductive health industry, offering women long-term, effective contraceptive solutions. As the awareness surrounding family planning and reproductive health continues to rise, the demand for IUDs has witnessed significant growth. This market encompasses various product types, including hormonal and non-hormonal devices, catering to different user preferences and medical needs. The evolving landscape is influenced by technological advancements, changing societal norms, and increased government initiatives promoting reproductive health, making it a dynamic and competitive field.

Hormonal Intrauterine Devices (IUDs) Segment is Largest Due to Effectiveness and Convenience

Hormonal intrauterine devices (IUDs) have emerged as the largest segment within the IUD market, primarily due to their effectiveness and convenience. These devices release hormones, specifically progestin, which thickens cervical mucus and thins the uterine lining, thereby preventing pregnancy. The effectiveness of hormonal IUDs, which can last for several years, appeals to women seeking long-term contraception without the need for daily management. This has made them a popular choice among various age groups, particularly among women in their 25 to 34 years demographic, who are often at a stage in life where family planning is a priority.

The increasing acceptance of hormonal IUDs can also be attributed to extensive education and awareness campaigns highlighting their benefits. Health practitioners recommend them for women who may have contraindications to estrogen-containing contraceptives, thus widening the potential user base. As more healthcare providers become trained in IUD insertion and management, the usage of hormonal IUDs is expected to grow, solidifying their position as the dominant product type in the market.

Non-Hormonal (Copper) Intrauterine Devices (IUDs) Segment is Fastest Growing Due to Rising Demand for Non-Hormonal Options

The non-hormonal (copper) intrauterine devices (IUDs) segment is experiencing rapid growth, driven by increasing demand for non-hormonal contraceptive options. Copper IUDs work by creating an environment toxic to sperm, thereby preventing fertilization. As awareness about hormonal side effects grows, many women are seeking alternatives that do not involve hormones. The copper IUD’s ability to provide long-term contraception for up to 10 years, without the systemic effects of hormones, makes it particularly attractive to women who prefer natural or hormone-free options.

This growing preference aligns with broader societal trends towards natural health and wellness, encouraging a shift in consumer attitudes toward contraception. Additionally, the rising rate of copper IUD acceptance is being propelled by the expanding availability of these devices in healthcare settings. As educational resources increase, more women are becoming informed about the benefits and effectiveness of copper IUDs, further driving their adoption in the market.

Age Group 25 to 34 Years is Largest Due to Family Planning Focus

Among the various age groups, women aged 25 to 34 years represent the largest demographic in the intrauterine devices market. This age group typically encompasses women who are at the peak of their reproductive years and are actively seeking effective family planning methods. Many individuals in this bracket prioritize convenience and long-term solutions, making IUDs an ideal choice due to their low maintenance and high efficacy rates.

The significant engagement in family planning during these years, combined with increased awareness of contraceptive options, drives the demand for IUDs. Moreover, healthcare providers are increasingly recommending IUDs as suitable options for this age group, contributing to higher adoption rates. As societal norms evolve and discussions around reproductive health become more open, the 25 to 34 age group is expected to maintain its prominence in the intrauterine devices market.

Hospitals Segment is Largest Because Of Comprehensive Healthcare Services

The hospitals segment stands out as the largest end-use category for intrauterine devices. Hospitals provide comprehensive healthcare services, including reproductive health consultations, making them the primary setting for IUD insertions. The presence of specialized healthcare professionals and advanced medical facilities allows for the safe and efficient administration of IUD procedures, attracting many women seeking this form of contraception.

In addition, hospitals often implement educational programs to inform patients about their contraceptive options, leading to higher awareness and acceptance of IUDs. The increasing trend of outpatient procedures further enhances the role of hospitals in the IUD market, as patients often seek quick and effective solutions for family planning. The hospital segment is thus poised to remain a dominant force in the intrauterine devices market, providing both services and education to prospective users.

Fastest Growing Region is Asia-Pacific Due to Rising Awareness and Access

The Asia-Pacific region is identified as the fastest-growing market for intrauterine devices, driven by increasing awareness of reproductive health and access to contraceptive options. Countries in this region are witnessing significant improvements in healthcare infrastructure and family planning initiatives. Governments are actively promoting reproductive health programs, encouraging women to utilize effective contraceptive methods like IUDs.

Moreover, the cultural shift towards family planning and women’s health in Asia-Pacific countries, combined with the rising number of healthcare facilities offering IUD insertion services, is expected to fuel market growth. The region’s expanding population and the need for effective family planning solutions create a conducive environment for the proliferation of IUD usage, positioning Asia-Pacific as a key area of focus for market players.

Competitive Landscape and Leading Companies

The intrauterine devices market is characterized by a competitive landscape with several key players. Companies such as Bayer, CooperSurgical, and AbbVie Inc. (Allergan Plc) are prominent players, continuously innovating to enhance their product offerings. These companies engage in strategic partnerships, research and development initiatives, and marketing campaigns to maintain and expand their market presence.

The competitive dynamics in this market are further shaped by the introduction of new product variants, including advanced hormonal and non-hormonal IUDs, which cater to the diverse preferences of women. Additionally, companies are increasingly focusing on educational initiatives to raise awareness about the benefits of IUDs, thereby facilitating market growth. As the demand for effective and reliable contraceptive methods continues to rise, the intrauterine devices market is set for substantial development, driven by innovation and strategic market positioning.

Recent Developments:

• Bayer announced the launch of a new hormonal IUD designed to provide extended contraceptive benefits while minimizing side effects, targeting the growing demand for long-acting contraceptive options.
• CooperSurgical revealed its acquisition of a small biotech firm specializing in innovative reproductive health technologies, aimed at enhancing its IUD offerings and improving access to family planning solutions.
• AbbVie partnered with global health organizations to increase awareness and accessibility of IUDs, particularly in underserved regions, aiming to empower women with effective contraceptive options.
• Pregna International introduced a new line of eco-friendly copper IUDs made from sustainable materials, appealing to environmentally conscious consumers.
• Meril Life Sciences announced that it received regulatory approval for its new line of IUDs, enhancing its position in the market and expanding options for healthcare providers and patients alike.

List of Leading Companies:

• Bayer
• CooperSurgical, Inc.
• AbbVie Inc. (Allergan Plc)
• Mona Lisa N.V.
• SMB Corporation of India
• Pregna International Limited
• DKT International
• Medisafe Distribution Inc.
• HLL Lifecare Limited
• Ocon Medical Ltd.
• Meril Life Sciences Pvt. Ltd.
• Eurosurgical Ltd.

Report Scope: